Literature DB >> 30392758

Epidemiology and Overview of Gliomas.

Mary Elizabeth Davis.   

Abstract

OBJECTIVE: To present an overview of gliomas, review risk factors, and prognostic and predictive biomarkers. DATA SOURCES: Published manuscripts and textbook chapters.
CONCLUSION: Molecular genetic profiling is allowing for more specific characterization of gliomas and prediction of prognosis and treatment efficacy to individualize therapeutic plans of care. IMPLICATIONS FOR NURSING PRACTICE: Oncology nurses caring for patients with gliomas can broaden their understanding of emerging research on glioma risk factors and how specific biomarkers can help define glioma subtypes and guide clinical decisions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  biomarkers; epidemiology; gliomas; risk factors

Mesh:

Substances:

Year:  2018        PMID: 30392758     DOI: 10.1016/j.soncn.2018.10.001

Source DB:  PubMed          Journal:  Semin Oncol Nurs        ISSN: 0749-2081            Impact factor:   2.315


  42 in total

1.  Partnership for defining the impact of 12 selected rare CNS tumors: a report from the CBTRUS and the NCI-CONNECT.

Authors:  Gabrielle Truitt; Haley Gittleman; Rebecca Leece; Quinn T Ostrom; Carol Kruchko; Terri S Armstrong; Mark R Gilbert; Jill S Barnholtz-Sloan
Journal:  J Neurooncol       Date:  2019-06-17       Impact factor: 4.130

2.  ceRNA network of lncRNA MIR210HG/miR-377-3p/LMX1A in malignant proliferation of glioma cells.

Authors:  Zhikuan Yu; Ningwei Che; Yeting He; Bo Zhang
Journal:  Genes Genomics       Date:  2022-10-05       Impact factor: 2.164

3.  RNF216 Alleviates Radiation-Induced Apoptosis and DNA Damage Through Regulating Ubiquitination-Mediated Degradation of p53 in Glioblastoma.

Authors:  Songwang Xie; Zhen Hong; Yan Li; Junyong Wang; Jian Wang; Shaoquan Li; Yongchang Liu
Journal:  Mol Neurobiol       Date:  2022-05-20       Impact factor: 5.682

4.  Quality of Life after Surgical Treatment of Brain Tumors.

Authors:  Agnieszka Królikowska; Karolina Filipska-Blejder; Renata Jabłońska; Beata Haor; Anna Antczak-Komoterska; Monika Biercewicz; Lech Grzelak; Marek Harat; Robert Ślusarz
Journal:  J Clin Med       Date:  2022-06-28       Impact factor: 4.964

5.  High expression of N-type calcium channel indicates a favorable prognosis in gliomas.

Authors:  Guibin Li; Bhaskar Roy; Xiaoqiang Huang; Yafei Mu; Jiecheng Yuan; Yang Xia; Yue Song; Ziyue Peng
Journal:  Medicine (Baltimore)       Date:  2022-07-01       Impact factor: 1.817

6.  LncRNA RP11-84E24.3 drives tumorigenesis and epithelial-to-mesenchymal transition of glioma cells by promoting TFAP2C-mediated activation of SNAI1.

Authors:  Lisha Chang; Jingyue Wang; Fuling Zhou; Dali Wang; Ruiying Chen; Yunhe Zhang; Jiang Zhang
Journal:  J Neurooncol       Date:  2020-10-30       Impact factor: 4.130

7.  LncRNA PITPNA-AS1 stimulates cell proliferation and suppresses cell apoptosis in glioblastoma via targeting miR-223-3p/EGFR axis and activating PI3K/AKT signaling pathway.

Authors:  Sumin Geng; Shaohua Tu; Weilun Fu; Jianbo Wang; Zhenwei Bai
Journal:  Cell Cycle       Date:  2021-09-01       Impact factor: 5.173

Review 8.  The Basis and Advances in Clinical Application of Cytomegalovirus-Specific Cytotoxic T Cell Immunotherapy for Glioblastoma Multiforme.

Authors:  Amin Daei Sorkhabi; Aila Sarkesh; Hossein Saeedi; Faroogh Marofi; Mahnaz Ghaebi; Nicola Silvestris; Behzad Baradaran; Oronzo Brunetti
Journal:  Front Oncol       Date:  2022-04-19       Impact factor: 5.738

9.  Downregulation of LUZP2 Is Correlated with Poor Prognosis of Low-Grade Glioma.

Authors:  Yong Li; Gang Deng; Yangzhi Qi; Huikai Zhang; Hongxiang Jiang; Rongxin Geng; Zhang Ye; Baohui Liu; Qianxue Chen
Journal:  Biomed Res Int       Date:  2020-07-09       Impact factor: 3.411

10.  Prognostic Nomograms for Primary High-Grade Glioma Patients in Adult: A Retrospective Study Based on the SEER Database.

Authors:  Yi Yang; Mingze Yao; Shengrong Long; Chengran Xu; Lun Li; Yinghui Li; Guangyu Li
Journal:  Biomed Res Int       Date:  2020-07-23       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.